News
IHE
68.30
0.00%
0.00
Weekly Report: what happened at IHE last week (0715-0719)?
Weekly Report · 1d ago
Should You Invest in the SPDR S&P Pharmaceuticals ETF (XPH)?
NASDAQ · 6d ago
ASCO Annual Meeting 2024: Breakthrough Treatments Hint At Renewed Hope For Patients And Investors
Seeking Alpha · 6d ago
Weekly Report: what happened at IHE last week (0708-0712)?
Weekly Report · 07/15 12:00
Bristol-Myers Squibb's Q2 2024 Earnings: What to Expect
Bristol-Myers Squibb Company (BMY) is expected to unveil its fiscal Q2 earnings results before the market opens on Friday, Jul. 26. The biotech giant is a global leader in biopharmaceuticals. The company's shares have fallen 21.2% over the past year.
Barchart · 07/15 09:32
Should You Invest in the VanEck Pharmaceutical ETF (PPH)?
NASDAQ · 07/09 10:20
Weekly Report: what happened at IHE last week (0701-0705)?
Weekly Report · 07/08 12:03
CDT Insider Sentiment June 2024: Keep Your Seatbelt Fastened
Seeking Alpha · 07/04 02:30
Midyear Equity Outlook - Investing Beyond The Megacaps
Home Investing Strategy Portfolio Strategy Midyear Equity Outlook - Investing Beyond The Megacaps by Nelson Yu. The best performing sector has been technology with all of the AI powering the technology gains. Inflation has actually been more selective than the world expected. Lagging the stock market is consumer, not surprisingly.
Seeking Alpha · 07/03 12:00
Weekly Report: what happened at IHE last week (0624-0628)?
Weekly Report · 07/01 12:03
Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now?
NASDAQ · 06/28 10:20
From AI To Green Metals: Strategic Investments For A Changing World
Green transition is driving this unprecedented demand for metals and minerals. By 2030, we will need 50 new lithium mines to meet the growing demand for electric vehicles (EVs) and renewable energy infrastructure. The clean appearance of EVs, solar panels, and windmills belies the dirty reality that they require lots and lots of mining.
Seeking Alpha · 06/27 01:15
Weekly Report: what happened at IHE last week (0617-0621)?
Weekly Report · 06/24 12:14
Can Eli Lilly ETFs Surge on Approval of Alzheimer's Drug?
NASDAQ · 06/19 17:00
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?
NASDAQ · 06/18 10:20
Weekly Report: what happened at IHE last week (0610-0614)?
Weekly Report · 06/17 12:01
Weekly Report: what happened at IHE last week (0603-0607)?
Weekly Report · 06/10 12:05
What The 2024 Elections Could Mean For Health Care Investors
Health care spending now accounts for 17% of the U.S. GDP. Election year volatility could mean opportunity for health care investors. The fate of medical exchanges and providers could be impacted by the election outcome. The outcome of the presidential election in 2024 could have implications for the health care sector.
Seeking Alpha · 06/08 06:20
Friday's ETF Movers: IHE, SIL
NASDAQ · 06/07 16:12
How Is Johnson & Johnson's Stock Performance Compared to Other Pharmaceutical Stocks?
Johnson & Johnson (JNJ) is a global healthcare powerhouse valued at $355.71 billion by market cap. Shares of JNJ are currently trading 17.1% below their 52-week high of $175.97. The stock has declined 8.8% over the past three months, underperforming the iShares U.S. Pharmaceuticals ETF.
Barchart · 06/06 10:12
More
Webull provides a variety of real-time IHE stock news. You can receive the latest news about iShares US Pharmaceuticals ETF through multiple platforms. This information may help you make smarter investment decisions.